D-Wave Quantum stock pops today as QBTS outperforms on year-end options buzz

D-Wave Quantum stock pops today as QBTS outperforms on year-end options buzz

NEW YORK, December 30, 2025, 1:03 PM ET — Regular session

  • D-Wave Quantum shares rose about 2.6% to $26.82, outpacing a slightly lower broader market.
  • Quantum “pure-play” peers IonQ, Rigetti and Quantum Computing also traded higher in the regular session.
  • Traders are watching options-implied volatility and the company’s January CES Foundry appearance for any commercial updates.

D-Wave Quantum Inc. shares climbed on Tuesday, extending a choppy year-end stretch for quantum-computing stocks as the group again outperformed a flat-to-weaker U.S. market.

The move matters because quantum names have become a high-beta pocket of the tech market, with swings amplified by thin holiday liquidity and active retail trading. Investors.com said the group saw a late-December pop followed by profit-taking in the sessions that followed.

D-Wave has been one of the sector’s standout gainers in 2025, but the stock remains well off its highs, underscoring how quickly sentiment can shift heading into 2026.

Shares of the Palo Alto, California-based company were up 2.6% at $26.82 in afternoon trading, after closing Monday at $26.15.

The broader backdrop was subdued: the S&P 500 and Nasdaq were both down about 0.06% on the session, while the Dow was off about 0.15%.

The rally in QBTS came alongside gains in other quantum-computing stocks, with IonQ up about 2%, Rigetti up about 1% and Quantum Computing up about 1% in the regular session.

Company news has been sparse in the past week; D-Wave’s most recent press release was on Dec. 22, when it said it will sponsor the CES Foundry in Las Vegas on Jan. 7-8, 2026.

In that release, D-Wave executive Murray Thom said the CES appearance “signals that the technology is quickly moving into the mainstream,” a message the company is expected to reprise as investors look for concrete customer traction. D-Wave Quantum

Derivatives activity is also in focus. TheFly said options flow in QBTS was modestly bullish, with calls leading puts and 30-day implied volatility near 96 — options-market shorthand for expectations of bigger day-to-day swings.

TheFly estimated the implied volatility level translated into an expected daily move of about $1.55, a reminder that the stock can gap sharply even without a headline.

For investors new to the space, D-Wave markets “quantum annealing,” a quantum approach aimed at finding good solutions to complex optimization problems, and it also says it is developing gate-model systems, a more general-purpose quantum computing architecture. D-Wave Quantum+1

Before the next major company update, traders are watching whether QBTS can hold recent support near the mid-$20s in thin year-end trading, and whether January events — CES Foundry and the Qubits 2026 user conference set for Jan. 27-28 in Florida, according to an SEC filing — generate new commercial detail.

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Taiwan Semiconductor

NYSE: TSM 96 / 100
#2 BUY

AerCap

NYSE: AER 95 / 100
#3 BUY ON PULLBACK

Constellation Energy

NASDAQ: CEG 93 / 100
#4 BUY

Walt Disney

NYSE: DIS 90 / 100
#5 ACCUMULATE

American International Group

NYSE: AIG 87 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Target stock slips today as activist pressure stays in focus — what investors are watching next
Previous Story

Target stock slips today as activist pressure stays in focus — what investors are watching next

Corcept stock slides nearly 9% as FDA decision deadline arrives — what’s driving CORT today
Next Story

Corcept stock slides nearly 9% as FDA decision deadline arrives — what’s driving CORT today